(NASDAQ: UNIS; ASX: UNS) announced that it intends to release its financial results for the fiscal 2012 first quarter ended September 30, 2011 after market trading ends on Wednesday, November 9, 2011.
Management has scheduled a conference call for 4:30 p.m. U.S. Eastern Standard Time on Wednesday, November 9, 2011 (Thursday, November 10, 2011 at 8:30 AM AEDT), to review the Company's financial results, market trends, and future outlook. The conference call will be broadcast over the Internet as a "live" listen only Webcast.
To listen, please go to: http://ir.unilife.com/events.cfm
Listeners are urged to login approximately 20 minutes before the conference call is scheduled to begin in order to register, as well as download and install any necessary audio software.
An archive of the webcast will be available for 30 days after the call.
About Unilife Corporation
Unilife Corporation is a U.S.-based developer, manufacturer and supplier of advanced drug delivery systems with state-of-the-art facilities in Pennsylvania. Established in 2002, Unilife works with pharmaceutical and biotechnology companies seeking innovative devices for use with their parenteral drugs and vaccines. Unilife has developed a broad, differentiated proprietary portfolio of its own injectable drug delivery products, including the Unifill® and Unitract® product lines of safety syringes with automatic, operator controlled needle retraction. Unifill represents the world's first prefilled syringe technology integrating safety within the primary drug container. The products are ideally positioned to help pharmaceutical companies maximize the lifecycle of their injectable drugs and enhance patient care. Unifill syringes, together with other devices that are part of the Unilife technology platform, can either be supplied to pharmaceutical customers ready for use, or customized to address the specific requirements of targeted novel drugs. For more information on Unilife, please visit www.unilife.com. ?